Hemophilia Clinical Trials

Duarte : City of Hope Updated

Immune Tolerance Induction Study in Patients with Severe Type A Haemophilia with Inhibitor after Failure of a Previous Induction of Immune Tolerance with FVII Concentrates without Von Willebrand Factor Rescue

Duarte : City of Hope Updated

Inhibitor Development in Previously Untreated Patients (PUPs) or Minimally Blood Component-Treated Patients (MBCTPs) When Exposed to Plasma-Derived von Willebrand Factor-Containing Factor VIII (VWF/FVIII) Concentrates and to Recombinant Factor VIII (rFVIII) Concentrates: An Independent, International, Multicentre, Prospective, Controlled, Randomised, Open Label, Clinical Trial

View More »

Orange : Children's Hospital of Orange Co.

Clinical Trial of Factor XIII Concentrate

Sacramento : UC Davis Health System Internal Medicine: Hematology & Oncology

A Phase I Safety, Pharmacokinetics and Pharmacodynamics Study of Recombinant Factor VIIa in Adult Patients With Hemophilia A or B

Chicago : RUSH Hemophilia & Thrombophilia Center

A Phase I Safety, Pharmacokinetics and Pharmacodynamics Study of Recombinant Factor VIIa in Adult Patients With Hemophilia A or B

Toronto : The Hospital for Sick Children

Validation of Ultrasound as a Diagnostic Tool for Assessment of Hemophilic Arthropathy of Knees and Ankles

Leiden : Centre for Human Drug Research

A Phase I Safety, Pharmacokinetics and Pharmacodynamics Study of Recombinant Factor VIIa in Adult Patients With Hemophilia A or B

Many Locations : Updated

Comparison of Efficacy, Safety and Costs of Recombinant FVIII Products Between On-demand and Secondary Prophylaxis Groups in Haemophilia A Patients